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Abstract
Although single chi-square analysis of the North American Rheumatoid Arthritis Consortium
(NARAC) data identifies many single-nucleotide polymorphisms (SNPs) with p-values less than
0.05, none remain significant after Bonferroni correction. In contrast, CHROMSCAN evades heavy
Bonferroni correction and auto-correlation between SNPs by using composite likelihood to model
association across all markers in a region and permutation to assess significance. Analysis by
CHROMSCAN identifies a 36-kb interval that includes the most significant SNP (msSNP) observed
in a 10-Mb target suggested by linkage. Unexpectedly, stratification by gender and age of onset
shows that association evidence comes almost entirely from females with age of onset less than 40.
Combining evidence from a meta-analysis of linkage studies and three subsets of the NARAC data
provides significant evidence for a determinant of rheumatoid arthritis in a 36-kb interval and
illustrates the principle that estimates of location and its information are more powerful than
estimates of p-values alone.
Background
Initially, linkage mapping dealt with rare and highly pen-
etrant genes. Without cytogenetic assignment, the pre-
ferred strategy was segregation analysis to determine all
relevant parameters except recombination, followed by
linkage analysis to determine recombination frequency
[1]. Complex inheritance with uncertain segregation
parameters proved much more difficult, giving rise to
many unconfirmed claims based on microsatellites and
leading to meta-analysis without point locations [2]. The
HapMap project provides dense SNPs that can be used to
localize causal loci with or without pedigrees. This proce-
dure, called association mapping, revolutionized identifica-
tion of disease genes. Recent developments of linkage
disequilibrium units (LDU), composite likelihood, con-
trol of auto-correlation, and meta-analysis are incorpo-
rated into the CHROMSCAN program [3,4] to increase its
precision for association mapping. Here we use these
methods to establish the location and weight of evidence
for a gene predisposing to rheumatoid arthritis.
Methods
Data preparation
The data, provided by NARAC (North American Rheuma-
toid Arthritis Consortium) consist of 2300 single-nucle-
otide polymorphisms (SNPs) in a 10-Mb region of 18q21
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with linkage evidence in U.S. and French scans [5]. Illu-
mina genotyped these markers in 460 cases and 460 con-
trols, matched for age and gender, from New York. The
genotypic data for controls were screened and 7 SNPs with
 > 10 for the Hardy-Weinberg test [6] were removed,
leaving 2293 to be analyzed. CHROMSCAN requires
SNPs to be located on both physical and LDU scales.
Physical locations were taken from build 35 of the human
genome sequence. Unlike physical maps, study-specific
and various LDU maps are available, corresponding to the
four HapMap samples separately and combined (CEU,
CHB, JPT, YRI, and cosmopolitan). The LDU map with the
highest SNP density and population attributes closest to
the experimental data should be optimal. We therefore
used LDU locations relative to the CEU HapMap data with
a density of 1 SNP per 863 bp compared to 1 SNP per
4139 bp in the NARAC data. We also used the kilobase
map to determine the robustness and power of LDU maps
compared with physical maps.
LDU map construction
The theory for constructing LDU maps has been described
[7]. Briefly, the LDU distance for the ith SNP interval is
given by εidi, where εi describes the exponential decline of
association with physical distance di in kb. Values of εi are
estimated by composite likelihood that fits the Malecot
model [8] to multiple pairwise diplotype data. The Male-
cot equation, given by  , uses
additional parameters to describes association at the last
major bottleneck (M), and residual association at large
distance (L) to predict rho (ρ), the probability of associa-
tion.
Association mapping
The CHROMSCAN program [3] uses a model similar to
LDU maps except the exponential term is replaced by
εΔ(Si - S) to estimate the location (S) of a disease gene,
where Si is the location of the ith marker in kilobases or
LDU. The Kronecker Δ is used for map direction and
assures a correct sign, with Δ = 1 if Si ≥ S or -1 if Si <S. To
calculate the expected association with distance, zi, the
model becomes  , where M is
diminished by complex inheritance and L is the associa-
tion at large distance. The observed association   is
determined by a 2 × 2 table between affection status and
the two alleles of each SNP to give   and
, where ad - bc ≥ 0 and b ≤ c is ensured
by rearrangement of columns and rows [9]. Given the
observed associations  , the Malecot parameters are esti-
mated iteratively using composite likelihood, which
evades a heavy Bonferroni correction by combining infor-
mation over all loci within a region as
, where   and zi are the observed and
expected association values, respectively, at the ith SNP.
Their squared difference is weighted by information (Ki)
which is estimated as:  , where   is the Pear-
son   from the 2 × 2 table.
Sub-hypotheses of the Malecot model are used to test for
a causal polymorphism. Model A, which estimates none
of the parameters and uses M = 0 with predicted L [10], is
taken as the null hypothesis H0 in which there is no asso-
ciation between affection status and SNPs. Model D esti-
mates M, S, and L. Therefore the ΛA - ΛD comparison tests
for a disease determinant at location S. For both models,
ε is fixed to 1 for the LDU map and to a value of ε deter-
mined from pairwise marker-by-marker association data
for the kilobase map. In order to account for autocorrela-
tion between SNPs as a result of LD, the significance of
evidence is determined by a rank-based permutation test
[3].
Three separate analyses of the data were performed by
CHROMSCAN. The first is a preliminary screen of the
entire 10-Mb bin, which is divided into 18 nonoverlap-
ping regions, each with at least 30 SNPs and covering at
least 10 LDUs. To determine accurate levels of signifi-
cance, the number of permutation replicates must
approach the actual level of significance so that interpola-
tion of the variance under H1 is reliable. To minimize
computation time, the initial analysis was restricted to
100 replicates. Significant regions identified by the initial
screen were re-analyzed separately using 1000 and 5000
replicates in order to verify convergence. To demonstrate
the power of LDU maps, this analysis was repeated using
the kilobase map and two estimates of the exponential
decline ε derived from the significant region and the 10-
Mb region [11]. The risk for rheumatoid arthritis is ele-
vated in females, especially with late onset (≥35–≤60)
[12]. Our third analysis therefore stratified cases into three
groups corresponding to males, females with onset ≤39,
and females with onset ≥40. The partition of females
around an onset age of 40 was chosen to give approxi-
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mately equal numbers of 'early' and 'late' onset cases.
Unaffected controls for the three groups were all males
(with similar age and total number of individuals as
affected males), and females divided by current age to give
similar total numbers of individuals as cases, respectively.
This analysis was restricted to significant regions from the
initial screen and used 5000 replicates.
Results
Association mapping
Single chi-square analyses of the 10-Mb region identifies
125 SNPs with p < 0.05, none of which reach significance
after Bonferroni correction (0.05/2293). The initial screen
by CHROMSCAN divides the 18q21 bin into 18 nonover-
lapping regions. Although the most significant SNP
(msSNP, rs3745064) occurs in region 6, the next msSNP
in region 11 is deceptively close in terms of significance,
and several other regions contain suggestive SNPs (Table
1). In contrast, the composite likelihood approach, which
models association across all markers in a region, identi-
fies region 6 as the only significant region (p = 0.01259).
The intensive screen of region 6 identified a large increase
in significance between 100 and 1000 replicates, which is
attributed to the relationship between number of repli-
cates and significance, while the small decrease in signifi-
cance between 1000 and 5000 replicates suggests that
convergence has been achieved (Table 2). These analyses
estimate a causal locus (S) at 53308 kb.
The CHROMSCAN analysis of region 6 was repeated
using the kilobase map so that its performance can be
compared with the LDU map. Using a kilobase map
requires specification of the exponential decline ε [11].
Two values of ε, corresponding to the 10 Mb interval
(0.021) or region 6 alone (0.031), were investigated.
Despite the large difference between ε values for the kilo-
base map, the significance level and location were almost
identical. However, the ratios of   indicate that the kilo-
base maps have a relative efficiency of 75% compared
with an LDU map at 1000 replicates (Table 2).
Because King et al. [12] demonstrated that the risk for
rheumatoid arthritis is elevated in females, especially with
late onset, we stratified cases into three groups according
to sex and age of onset. The effect of this stratification is
highly suggestive despite its crudeness (Table 3) and small
sample sizes. Females with onset ≤39 account for most of
the association. The other two classes give such small chi-
square values that they would undoubtedly be assigned to
other regions if the partition test had not been restricted
to region 6 on the pooled evidence. However, when con-
sidering region 6 alone, there is remarkable agreement
between point estimates for 'early' and 'late' onset females
and those from males. At this time it is impossible to say
whether this consistency is caused by imperfectly divided
onset groups or a small effect at late age.
χ1
2
Table 1: Regions screened with 100 replicates
Region No. SNPs First kb Last kb
 for msSNP
Composite likelihood
LOD1 p-Values
1 256 48896 49928 6.58 0.05948 0.01291 0.80701
2 238 49935 51009 11.18 0.00691 0.00150 0.93358
3 197 51010 51919 10.83 2.22538 0.48323 0.13584
4 132 51926 52398 4.42 0.05000 0.01086 0.82274
5 241 52398 53262 5.90 0.00011 0.00002 0.99158
6 113 53262 53596 12.25 6.22830 1.35246 0.01259
7 74 53599 53919 6.84 2.95054 0.64070 0.08592
8 38 53920 54006 1.75 0.78229 0.16987 0.37637
9 103 54008 54448 6.64 1.71241 0.37185 0.19074
10 49 54496 54974 5.23 0.50780 0.11027 0.47592
11 70 54977 55285 12.06 0.34910 0.07581 0.55438
12 60 55286 55381 10.89 0.00011 0.00002 0.99147
13 89 55382 55634 4.24 0.13215 0.02870 0.71588
14 29 55641 55838 2.42 0.05010 0.01088 0.82258
15 134 55839 56399 5.66 0.97584 0.21190 0.32321
16 209 56408 57248 3.87 0.00166 0.00036 0.96744
17 55 57253 57545 9.51 1.51557 0.32910 0.21834
18 200 57548 58415 3.86 1.58390 0.34394 0.20826
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Linkage
Choi et al. [13] reported a meta-analysis of four linkage
studies with microsatellites in a 10-Mb bin of chromo-
some 18. The results from this study were reported as p-
values without estimates of location or standard errors.
Without this information, the power for meta-analysis is
reduced because the sum of two   values must be con-
verted back to   and LOD1 instead of weighting esti-
mates of location by their information. Perhaps because
of this inefficiency, the combined LOD1 from this meta-
analysis is 1.542, well below the conventional value of 3
for asserting significance. The corresponding p-value in
large-sample theory is 0.007714, providing strong but
inconclusive evidence for localization in the 18q21
region. Despite its limitations, linkage contributes evi-
dence that should not be ignored.
Joint significance of linkage and association
The simplest meta-analysis is based on n  independent
samples, the ith of which contributes a Pi value that on the
null hypothesis is uniformly distributed. Then -2 ln Pi
would be distributed as  , with  . This is
the only test applicable to data that do not provide an esti-
mate of location Si and information Ki, but has three dis-
advantages; first, equal weight is given to samples with
different standard errors; second, there is no test of homo-
geneity; and third, there is no point estimate to become
more precise as n increases. As a consequence, much infor-
mation is lost. Accepting these limitations and assuming
accuracy of the P estimates, Table 4 shows that combining
pooled association with linkage provides suggestive evi-
dence to assign a gene for rheumatoid arthritis to the
18q21.31 interval. The LOD1 with no Bonferroni correc-
tion is 2.676 for linkage and pooled association. When
location and information weight are available, the evi-
dence for association is combined by determination of the
difference between   with n degrees of freedom and
, which tests for heterogeneity with n - 1
degrees freedom where  . When the strati-
fied association samples are combined in this manner, the
heterogeneity test is negligible. As expected, power is
increased when pooled with linkage (LOD1 = 3.401, p =
0.000076). Even with conservative adjustment of the p-
value to account for the 18 regions tested by association
(18*0.000569), and despite strong although not formally
significant, evidence from linkage for at least one causal
gene in the 18 regions, the meta-analysis is supportive
(LOD1 = 2.327, p = 0.001062). We conclude that evidence
χ1
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Table 3: Stratification by gender and age of onset (5000 replicates)
Sex Age of onset Case/Control SK SE LOD1 p
kb LDU
M - 95 95 53308.370 1195.126 3.13 0.57 0.0299 0.007 0.8624
F ≤39 193 192 53308.370 1195.126 47.3 0.15 11.844 2.575 0.0006
F ≥40 170 173 53262.482 1194.474 0.04 5.18 0.0183 0.004 0.8589
χ1
2
Table 2: Intensive screening of region 6
No. replicates Mapa ε SK SE LOD1 p
kb LDU
100 LDU 1.000 53308.370 1195.126 41.233 0.1557 6.2283 1.3525 0.0126
1000 LDU 1.000 53308.370 1195.126 44.329 0.1502 9.6876 2.1036 0.0019
5000 LDU 1.000 53308.370 1195.126 36.611 0.1589 8.3245 1.8076 0.0039
1000 kb 0.021 53306.868 1195.126 0.0195 7.1529 7.2178 1.5673 0.0072
1000 kb 0.031 53307.748 1195.126 0.0367 5.2220 7.2910 1.5832 0.0069
aValues of information (K) and standard error (SE) are relative to SLDU and Skb, indicated by the map column, when using the LDU and kb map, 
respectively.
χ1
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for region 6 is probative, with linkage and association
both providing critical evidence despite lack of a point
estimate and information weight for linkage.
Discussion
This application demonstrates that CHROMSCAN is a
powerful approach for gene mapping in complex inherit-
ance, which is applicable to meta-analysis. Obvious exten-
sions include identification of a causal locus and more
precise definition of the phenotype associated with it. The
95% confidence interval, given by S ± 1.96 (SE), covers 36
kb between 53296 and 53332 kb and includes the msSNP
rs3745064. Although no described genes are within this
region, it does include four human mRNAs from Gen-
Bank: CR590917, AK021217, AK124558, and BC01314,
all to the left of point estimate (S). Of these, CR590917
appears to be the most interesting because it is expressed
within T cells and could therefore conceivably affect risk
for rheumatoid arthritis. Finally, geneid [14] and Genscan
[15] predict a similar gene, which is the closest annotated
sequence to the point estimate (S). However, nothing is
known about the function of this gene and its reliability is
questionable. The fascinating directions revealed by these
findings have yet to be explored. Ultimately, interaction
with other contributing loci and environmental factors
will be recognized and, more importantly, locus-specific
treatment will be found.
Recent papers testify to growing interest in meta-analysis,
looking backward to linkage rather than forward to asso-
ciation mapping. Rank permutation provides a valid sig-
nificance test, but the genome search meta-analysis
(GSMA) that uses regional assignment with arbitrary
weights cannot give a reliable estimate of effect and there-
fore has low power for estimating point location and
detecting heterogeneity [16,17]. Most of the few papers on
association mapping assume family data rarely feasible
for diseases of late onset and are restricted to single mark-
ers without composite likelihood to estimate both loca-
tion S and its information K. One manuscript presented in
GAW15 that used meta-analysis without those estimates
failed to detect the strong signal on chromosome 18q
demonstrated by composite likelihood [18].
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